4AB:ETR
AbbVie Common Stock
€266.60
arrow_downward
-0.56%(-1.50) 1D
Nov 13, 5:35:48 PM GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 4AB...
Open
€266.80
High
€268.50
Low
€266.10
Mkt. cap
521.50B
Avg. vol.
538.00
Volume
225.00
52-wk high
€270.70
52-wk low
€162.85
No. of employees
57K
Open
€266.80
High
€268.50
Low
€266.10
Mkt. cap
521.50B
Avg. vol.
538.00
Volume
225.00
52-wk high
€270.70
52-wk low
€162.85
No. of employees
57K
News stories
From web sources and news partners
The Motley Fool
·
1 day ago
Pfizer's 5.9% Yield vs. AbbVie's 53-Year Dividend Streak: Which Stock Is the Better Buy?
Yahoo Finance
·
1 day ago
AbbVie (ABBV) Stock Looks Below Fair Value After Strong Cash Flow Growth
Smartkarma
·
1 day ago
AbbVie Raises 2026 Revenue Guidance to $67.8 Billion: Can Skyrizi and Rinvoq Sustain Growth?
NewsBreak: Local News & Alerts
·
2 days ago
3 Pharmaceutical Stocks That Offer Safety and Growth
Profile
AbbVie Inc., also known as AbbVie, is an American pharmaceutical company headquartered in North Chicago, Illinois. AbbVie produces drugs to treat a wide range of medical issues.
The company is ranked sixth on the list of largest biomedical companies by revenue. It is ranked 77th on the Fortune 500 and 108th on the Forbes Global 2000. The name "AbbVie" is derived from a combination of "Abbott", the name of its former parent company, with "vie", intended as a reference to a Latin root meaning 'life'. Wikipedia
About AbbVie Common Stock
CEORobert A. Michael
Employees57K
FoundedApr 10, 2012
HeadquartersNorth Chicago, Illinois, United States
SectorHealth Care
IndustryBiotechnology
Websiteabbvie.com